Lv7
4360 积分 2021-05-06 加入
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
2天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
2天前
已完结
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
2天前
已完结
Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors
17天前
已完结
Discovery of oxazole-based PDE4 inhibitors with picomolar potency
17天前
已完结
Discovery of oral and inhaled PDE4 inhibitors
17天前
已完结
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
17天前
已完结
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
17天前
已完结
Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors
25天前
已完结
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic Disorders
1个月前
已完结
皖公网安备34019202002308
